Solulink Completes Equity Financing for HybriLink™ Antibody-Labeling Technology

News   Jul 19, 2013

 
Solulink Completes Equity Financing for HybriLink™ Antibody-Labeling Technology
 
 
 

RELATED ARTICLES

Funding Approved to Further Metabolomics Research

News

The NIH Common Fund Metabolomics Program has been approved for a second stage of support from fiscal years 2018-2021.

READ MORE

Two Studies Provide Significant Hope in the Fight Against Antibiotic Resistance

News

Two recent studies led by the University of Bristol provide significant new hope in the fight against antibiotic resistance.

READ MORE

Screening for Disease or Toxins in a Drop of Blood

News

Scientist have developed a multinozzle emitter array (MEA), a silicon chip that can dramatically shorten the time it takes to identify proteins, peptides, and other molecular components within small volumes of biological samples.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE